000 | 04674nam a22009017a 4500 | ||
---|---|---|---|
008 | 190521s20192019 xxu||||| |||| 00| 0 eng d | ||
022 | _a1878-0938 | ||
024 | _a10.1016/j.carrev.2019.02.015 [doi] | ||
024 | _aS1553-8389(19)30148-4 [pii] | ||
040 | _aOvid MEDLINE(R) | ||
099 | _a31079816 | ||
245 | _aTranscatheter Aortic Valve Replacement in Patients With Symptomatic Severe Aortic Stenosis and Prior External Chest Radiation. | ||
251 | _aCardiovascular Revascularization Medicine. 20(5):376-380, 2019 05. | ||
252 | _aCardiovasc Revasc Med. 20(5):376-380, 2019 05. | ||
252 | _zCardiovasc Revasc Med. 20(5):376-380, 2019 May. | ||
253 | _aCardiovascular revascularization medicine : including molecular interventions | ||
260 | _c2019 | ||
260 | _fFY2019 | ||
265 | _sppublish | ||
266 | _d2019-05-21 | ||
268 | _aCardiovascular Revascularization Medicine. 20(5):376-380, 2019 May. | ||
501 | _aAvailable in print through MWHC library: 2002 - present | ||
520 | _aBACKGROUND/PURPOSE: Surgical aortic valve replacement (SAVR) in patients with symptomatic severe aortic stenosis (AS) and prior chest radiation is associated with poor outcomes in comparison with patients without prior radiation. Our objective was to compare clinical outcomes of patients with and without prior chest radiation undergoing transcatheter aortic valve replacement (TAVR) for symptomatic severe AS. | ||
520 | _aCONCLUSIONS: Thus, TAVR appears to be a safe treatment option in the short and medium term for patients with symptomatic severe AS and prior chest radiation. | ||
520 | _aCopyright (c) 2019. Published by Elsevier Inc. | ||
520 | _aMETHODS/MATERIALS: Between January 2003 and January 2017, 1150 patients underwent TAVR at our institution. Of these, 44 had prior chest radiation. Baseline demographic and clinical characteristics, procedural details, and clinical outcomes were prospectively collected. | ||
520 | _aRESULTS: Patients with prior chest radiation were younger, 76+/-13years, compared with those without prior chest radiation, 82+/-8years (p=0.002). Median Society of Thoracic Surgeons score for chest radiation patients was 7+/-4, compared to 8+/-5 in those without prior radiation. Despite higher prevalence of complete heart block, there was no significant difference between the 2 groups with regard to the need for permanent pacemaker implantation. There was a trend toward longer length of intensive care unit stay in chest radiation patients, but there was no significant difference in 30-day or 1-year mortality. | ||
546 | _aEnglish | ||
650 | _a*Aortic Valve Stenosis/su [Surgery] | ||
650 | _a*Aortic Valve/su [Surgery] | ||
650 | _a*Cancer Survivors | ||
650 | _a*Thorax/re [Radiation Effects] | ||
650 | _a*Transcatheter Aortic Valve Replacement | ||
650 | _aAged | ||
650 | _aAged, 80 and over | ||
650 | _aAortic Valve Stenosis/dg [Diagnostic Imaging] | ||
650 | _aAortic Valve Stenosis/mo [Mortality] | ||
650 | _aAortic Valve Stenosis/pp [Physiopathology] | ||
650 | _aAortic Valve/dg [Diagnostic Imaging] | ||
650 | _aAortic Valve/pp [Physiopathology] | ||
650 | _aDistrict of Columbia/ep [Epidemiology] | ||
650 | _aFemale | ||
650 | _aHeart Block/ep [Epidemiology] | ||
650 | _aHeart Block/th [Therapy] | ||
650 | _aHemodynamics | ||
650 | _aHumans | ||
650 | _aLength of Stay | ||
650 | _aMale | ||
650 | _aMiddle Aged | ||
650 | _aPrevalence | ||
650 | _aProspective Studies | ||
650 | _aRadiotherapy | ||
650 | _aRisk Factors | ||
650 | _aSeverity of Illness Index | ||
650 | _aTime Factors | ||
650 | _aTranscatheter Aortic Valve Replacement/ae [Adverse Effects] | ||
650 | _aTranscatheter Aortic Valve Replacement/mo [Mortality] | ||
650 | _aTreatment Outcome | ||
651 | _aMedStar Heart & Vascular Institute | ||
657 | _aJournal Article | ||
700 | _aAttaran, Saina | ||
700 | _aBen-Dor, Itsik | ||
700 | _aBuchanan, Kyle | ||
700 | _aGajanana, Deepakraj | ||
700 | _aIantorno, Micaela | ||
700 | _aKolm, Paul | ||
700 | _aOkubagzi, Petros | ||
700 | _aRogers, Toby | ||
700 | _aSatler, Lowell F | ||
700 | _aThourani, Vinod H | ||
700 | _aTorguson, Rebecca | ||
700 | _aWaksman, Ron | ||
700 | _aWeintraub, William S | ||
700 | _aZhang, Cheng | ||
790 | _aAttaran S, Ben-Dor I, Buchanan KD, Gajanana D, Iantorno M, Kolm P, Okubagzi PG, Rogers T, Satler LF, Thourani VH, Torguson R, Waksman R, Weintraub WS, Zhang C | ||
856 |
_uhttps://dx.doi.org/10.1016/j.carrev.2019.02.015 _zhttps://dx.doi.org/10.1016/j.carrev.2019.02.015 |
||
942 |
_cART _dArticle |
||
999 |
_c4239 _d4239 |